TrialPloS one2013

A randomized, double-blind, placebo-controlled assessment of BMS-936558, a fully human monoclonal antibody to programmed death-1 (PD-1), in patients with chronic hepatitis C virus infection.

David Gardiner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.